(Reuters) - Mead Johnson shares fell 8 percent on Thursday following the recall of some of its Emfamil baby formula from Wal-Mart Stores Inc after the death of a Missouri infant.
The infant tested positive for Cronobacter, a bacteria that has sometimes been linked to rare illnesses in newborns.
Walmart began the process of voluntarily removing the product -- Enfamil Newborn in a 12.5-ounce can -- from more than 3,000 U.S. stores late Monday night, a spokeswoman said.
Mead Johnson said it was confident that all of its products are safe when prepared, stored and used according to the label instructions.
"The batch of our product used by the child's family tested negative for Cronobacter when it was produced and packaged, and that has been reconfirmed from our batch records following this news," Mead Johnson spokesman Chris Perille said.
Mead Johnson shares were down $6.45, or 8.4 percent, at $70.03 on the New York Stock Exchange.
(Reporting By Martinne Geller in New York; Additional reporting by Lauren Keiper in Boston and Brad Dorfman in Chicago; Editing by Lisa Von Ahn)
Suspect in Custody After Shooting at Colorado Springs Planned Parenthood UPDATE: Three People Have Died, Shooter Identified | Christine Rousselle
Active Shooter Near Planned Parenthood Location in Colorado UPDATE: Suspect Has Surrendered to Police | Christine Rousselle
S.C. Woman Outdraws, Outshoots, And Kills CraigsList Robber - Bearing Arms - Guns Saving Lives, South Carolina
Planned Parenthood Shooter Finally Convinces Leftists that Beliefs Matter | RedState
Report: Active shooter at Colo. Springs Planned Parenthood; Update: Media amend reports, say shooting was 'near' Planned Parenthood
John Hawkins - 15 Excerpts That Show How Radical, Weird And Out of Touch College Campuses Have Become
An endorsement for #BlackLivesMatter to shut down all commerce in all cities
Importing Terrorism and Other American Values | Human Events
George Friedman - The Geopolitics of France: Maintaining Its Influence in a Changing Europe